Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CASP1 | P29466 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.32 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.32 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28106027 | 0.98 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL27560360 | 0.90 | TSHR (0.36) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL19725742 | 0.88 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL31208491 | 0.86 | MEN1 (0.39) | TSHRMAPK1MEN1KMT2ATHRB | |
| Di(Hydroxyethyl)Ether SCHEMBL18040258 | 0.85 | TSHR (0.53) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL1074759 | 0.85 | — | — | |
| SCHEMBL10044435 | 0.83 | MEN1 (0.55) | TSHRMAPK1MEN1KMT2ATHRB | |
| SCHEMBL31417823 | 0.82 | MEN1 (0.36) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL1016684 | 0.81 | BTN3A1 (0.31) | TSHRBTN3A1EPHX1 | |
| SCHEMBL14218036 | 0.81 | TSHR (0.41) | TSHRMAPK1MEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106103655-B | The method that pitch is extracted from oil-sand | 陶氏环球技术有限责任公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-106103655-A | The method extracting pitch from oil-sand | 陶氏环球技术有限责任公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20080103123-A1 | New compounds | BIOVITRUM (SE) | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103123-A1 | New compounds | GPR119, GPR139, GPR180 | TSHR 488/4885MAPK1 1638/4885MEN1 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.